Companies / Eloxx Pharmaceuticals, Inc. / Activity
Activity — Eloxx Pharmaceuticals, Inc.
39 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 28, 2026 | Aggarwal Sumit CEO | Exercise | Common Stock | $39.1K | +261K +18.48% | 1,672,756 41.44% of shares | low |
| Aug 14, 2025 | Aggarwal Sumit CEO | Exercise | Common Stock | $20 | +197K +98.47% | 396,810 9.83% of shares | low |
| May 27, 2026 | Domicilium Capital Partners LLC 10% owner | Other | Common Stock, $0.01 par value per share | $0 | -114K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Coastlands Capital LP 10% owner | Other | Common Stock | $0 | -1.3M -100.00% | 0 0.00% of shares | low |
| Sep 19, 2025 | Aggarwal Sumit CEO | Grant | Common Stock | $0 | +1.0M +252.01% | 1,396,810 34.60% of shares | low |
| Jun 10, 2026 | Domicilium Capital Partners LLC 10% owner | Other | Pre-funded Warrant | — | +362K +76.46% | 834,489 20.67% of shares | low |
| Jun 10, 2026 | Domicilium Capital Partners LLC 10% owner | Other | Pre-funded Warrant | — | +238K | 0 0.00% of shares | low |
| Jun 10, 2026 | Domicilium Capital Partners LLC 10% owner | Other | common stock, $0.01 par value per share | — | +362K | 361,578 8.96% of shares | low |
| Jun 10, 2026 | Domicilium Capital Partners LLC 10% owner | Other | common stock, $0.01 par value per share | — | +238K | 238,422 5.91% of shares | low |
| Jun 8, 2026 | Webster Stephen W Director | Grant | Stock Option (Right to Buy) | — | +14K | 13,587 0.34% of shares | low |
| Jun 8, 2026 | Walts Alan Edmund Director | Grant | Stock Option (Right to Buy) | — | +9K | 8,590 0.21% of shares | low |
| Jun 10, 2026 | Aggarwal Sumit CEO | Grant | Stock Option (Right to Buy) | — | +329K | 328,833 8.15% of shares | low |
| Jun 8, 2026 | Kjellson Nina S Director | Grant | Stock Option (Right to Buy) | — | +14K | 13,587 0.34% of shares | low |
| Jun 8, 2026 | Rubin Steven D Director | Grant | Stock Option (Right to Buy) | — | +4K | 4,018 0.10% of shares | low |
| May 27, 2026 | Domicilium Capital Partners LLC 10% owner | Other | Pre-funded Warrant | — | +114K +91.06% | 238,422 5.91% of shares | low |
| May 27, 2026 | Coastlands Capital LP 10% owner | Other | Pre-funded Warrant | — | +1.3M +4.26% | 30,612,243 758.39% of shares | low |
| Jan 24, 2026 | Rubin Steven D Director | Exercise | Restricted Stock Units | — | -2K -50.00% | 1,875 0.05% of shares | low |
| Sep 19, 2025 | Rubin Steven D Director | Grant | Stock Option (Right to Buy) | — | +180K | 179,854 4.46% of shares | low |
| Jan 24, 2026 | Rubin Steven D Director | Exercise | Common Stock | — | +2K +14.71% | 14,625 0.36% of shares | low |
| Feb 28, 2026 | Aggarwal Sumit CEO | Exercise | Stock Option (Right to Buy) | — | -261K -7.25% | 3,336,144 82.65% of shares | low |
| Jan 24, 2026 | Aggarwal Sumit CEO | Exercise | Restricted Stock Units | — | -15K -50.00% | 15,000 0.37% of shares | low |
| Sep 19, 2025 | Aggarwal Sumit CEO | Grant | Stock Option (Right to Buy) | — | +3.6M | 3,597,090 89.11% of shares | low |
| Aug 14, 2025 | Aggarwal Sumit CEO | Exercise | Stock Option (Right to Buy) | — | -43K -100.00% | 0 0.00% of shares | low |
| Aug 14, 2025 | Aggarwal Sumit CEO | Exercise | Stock Option (Right to Buy) | — | -25K -100.00% | 0 0.00% of shares | low |
| Aug 14, 2025 | Aggarwal Sumit CEO | Exercise | Stock Option (Right to Buy) | — | -69K -100.00% | 0 0.00% of shares | low |
| Aug 14, 2025 | Aggarwal Sumit CEO | Exercise | Stock Option (Right to Buy) | — | -60K -100.00% | 0 0.00% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Grant | Stock Option (Right to Buy) | — | +69K | 68,700 1.70% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Other | Stock Option (Right to Buy) | — | -69K -100.00% | 0 0.00% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Grant | Stock Option (Right to Buy) | — | +25K | 24,810 0.61% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Other | Stock Option (Right to Buy) | — | -25K -100.00% | 0 0.00% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Grant | Stock Option (Right to Buy) | — | +36K | 35,580 0.88% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Other | Stock Option (Right to Buy) | — | -36K -100.00% | 0 0.00% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Grant | Stock Option (Right to Buy) | — | +43K | 42,790 1.06% of shares | low |
| Oct 16, 2024 | Aggarwal Sumit CEO | Other | Stock Option (Right to Buy) | — | -43K -100.00% | 0 0.00% of shares | low |
| Feb 6, 2022 | Aggarwal Sumit CEO | Grant | Stock Option (Right to Buy) | — | +43K | 42,790 1.06% of shares | low |
| Jan 24, 2026 | Aggarwal Sumit CEO | Exercise | Common Stock | — | +15K +1.07% | 1,411,810 34.98% of shares | low |
| Jan 24, 2026 | Walts Alan Edmund Director | Exercise | Restricted Stock Units | — | -2K -50.00% | 1,875 0.05% of shares | low |
| Sep 19, 2025 | Walts Alan Edmund Director | Grant | Stock Option (Right to Buy) | — | +396K | 395,680 9.80% of shares | low |
| Jan 24, 2026 | Walts Alan Edmund Director | Exercise | Common Stock | — | +2K +13.69% | 15,567 0.39% of shares | low |